Persistence of Benefits of Continuous Subcutaneous Insulin Infusion in Very Young Children With Type 1 Diabetes: A Follow-up Report

Objective. Use of continuous subcutaneous insulin infusion (CSII) has increased dramatically in recent years, and pump therapy has been shown to be a safe and effective alternative to multiple daily injections in adults and older pediatric patients with type 1 diabetes. Its use in very young children, however, has been limited, although this group might be expected to benefit the most from CSII. The objective of this study was to analyze the CSII efficacy and safety data in very young children with type 1 diabetes from our Diabetes Clinic database. Methods. Glycosylated hemoglobin (HbA1c), severe hypoglycemia (SH), and ketoacidosis (DKA) in the year before CSII were compared with corresponding values during pump treatment in all children who started CSII before age 7. Results. Sixty-five children (mean age: 4.5 y at CSII initiation; range: 1.4–6.9 years; 28 girls; 3 black, 1 Hispanic) were analyzed for >162 patient-years of follow-up. Mean HbA1c (7.4 ± 1.0 prepump) decreased to 7.0 ± 0.9 after 12 months of CSII and continued to improve even after 4 years on CSII. The rate of SH was reduced by 53% (from 78 to 37/100 patient-years). Children who received daytime care from paid caregivers (n = 26) experienced significant reductions in HbA1c and hypoglycemia frequency. There were no episodes of DKA requiring emergency treatment in the year before CSII and 4 episodes (4 per 100 patient-years) after transition to pump. Conclusions. CSII is a durable and effective means of optimizing glycemic control in very young patients with type 1 diabetes and may be superior to multiple daily injections in minimizing the risk of severe hypoglycemia in this age group. Employment of paid caregivers does not preclude safe and effective use of CSII.

[1]  K. Knafl,et al.  Parents' reflections on managing their children's diabetes with insulin pumps. , 2004, Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing.

[2]  Dana Dabelea,et al.  Epidemiology of type 1 Diabetes Mellitus. , 2004, Advances in experimental medicine and biology.

[3]  J. Weissberg-Benchell,et al.  Insulin pump therapy: a meta-analysis. , 2003, Diabetes care.

[4]  T. Erlinger,et al.  Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. , 2003, Diabetes care.

[5]  W. Tamborlane,et al.  Constant vigilance: mothers' work parenting young children with type 1 diabetes. , 2003, Journal of pediatric nursing.

[6]  P. Czernichow,et al.  Incidence Data of Childhood-Onset Type I Diabetes in France During 1988–1997: The Case for a Shift Toward Younger Age at Onset , 2002, Pediatric Research.

[7]  M. Freemark,et al.  Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. , 2002, The Journal of pediatrics.

[8]  M. Rewers,et al.  Predictors of acute complications in children with type 1 diabetes. , 2002, JAMA.

[9]  John Pickup,et al.  Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials , 2002, BMJ : British Medical Journal.

[10]  W. Tamborlane,et al.  Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups , 2002, Pediatric diabetes.

[11]  Johan P Mackenbach,et al.  Income inequality and population health , 2002, BMJ : British Medical Journal.

[12]  P. Hougaard,et al.  Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study Group. , 2001, Diabetes care.

[13]  L. Molinari,et al.  Epidemiology of Type I diabetes mellitus in Switzerland: steep rise in incidence in under 5 year old children in the past decade , 2001, Diabetologia.

[14]  H. Chase,et al.  Continuous subcutaneous insulin infusion therapy for children and adolescents: an option for routine diabetes care. , 2001, Pediatrics.

[15]  G. Dahlquist,et al.  Analysis of 20 years of prospective registration of childhood onset diabetes time trends and birth cohort effects. Swedish Childhood Diabetes Study Group. , 2000 .

[16]  G. Dahlquist,et al.  Analysis of 20 years of prospective registration of childhood onset diabetes–time trends and birth cohort effects , 2000, Acta paediatrica.

[17]  V. Lánská,et al.  Type 1 diabetes mellitus in Czech children diagnosed in 1990–1997: a significant increase in incidence and male predominance in the age group 0–4 years , 2000 .

[18]  W. Tamborlane,et al.  Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. , 1999, Diabetes care.

[19]  F. Kaufman,et al.  Insulin pump therapy in Type 1 pediatric patients: now and into the year 2000 , 1999, Diabetes/metabolism research and reviews.

[20]  C. Howard,et al.  Ketoacidosis occurring in newly diagnosed and established diabetic children , 1998, Acta paediatrica.

[21]  D. Andrewes,et al.  Neuropsychological Complications of IDDM in Children 2 Years After Disease Onset , 1998, Diabetes Care.

[22]  P. Bingley,et al.  Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: time trend analysis , 1997, BMJ.

[23]  T. Jones,et al.  Hypoglycemia: Incidence and Clinical Predictors in a Large Population-Based Sample of Children and Adolescents with IDDM , 1997, Diabetes Care.

[24]  N. Tubiana-Rufi,et al.  Disparition des accidents hypoglycémiques sévères chez le très jeune enfant diabétique traité par pompe sous-cutanée , 1996 .

[25]  P. Czernichow,et al.  [Remission of severe hypoglycemic incidents in young diabetic children treated with subcutaneous infusion]. , 1996, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[26]  R. Ehrlich,et al.  Specific intellectual deficits in children with early onset diabetes mellitus. , 1988, Child development.

[27]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.

[28]  A. Drash,et al.  Cognitive deficits in adolescents who developed diabetes early in life. , 1985, Pediatrics.

[29]  P. Bougnères,et al.  Insulin pump therapy in young children with type 1 diabetes. , 1984, The Journal of pediatrics.

[30]  W. Tamborlane,et al.  Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. , 1979, The New England journal of medicine.